Atria Investments’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $523K | Sell |
6,311
-3,597
| -36% | -$298K | 0.01% | 1393 |
|
|
2025
Q1 | $804K | Sell |
9,908
-151
| -2% | -$12.2K | 0.01% | 1102 |
|
|
2024
Q4 | $906K | Buy |
10,059
+1,043
| +12% | +$93.9K | 0.01% | 1026 |
|
|
2024
Q3 | $891K | Buy |
9,016
+188
| +2% | +$18.6K | 0.01% | 1027 |
|
|
2024
Q2 | $818K | Buy |
+8,828
| New | +$818K | 0.01% | 1042 |
|
|
2020
Q1 | – | Sell |
-3,285
| Closed | -$312K | – | 1213 |
|
|
2019
Q4 | $312K | Buy |
+3,285
| New | +$312K | 0.01% | 960 |
|
|
2019
Q3 | – | Sell |
-3,307
| Closed | -$271K | – | 979 |
|
|
2019
Q2 | $271K | Buy |
3,307
+528
| +19% | +$43.3K | 0.01% | 782 |
|
|
2019
Q1 | $252K | Sell |
2,779
-216
| -7% | -$19.6K | 0.01% | 773 |
|
|
2018
Q4 | $215K | Buy |
2,995
+164
| +6% | +$11.8K | 0.01% | 787 |
|
|
2018
Q3 | $271K | Sell |
2,831
-454
| -14% | -$43.5K | 0.01% | 813 |
|
|
2018
Q2 | $313K | Buy |
3,285
+779
| +31% | +$74.2K | 0.01% | 728 |
|
|
2018
Q1 | $220K | Buy |
+2,506
| New | +$220K | 0.01% | 784 |
|